Ubs Group Ag Alnylam Pharmaceuticals, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 155,671 shares of ALNY stock, worth $38.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

155,671

Previous 156,583 0.58%

Holding current value

$38.1 Million

Previous $38 Million 12.54%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$233.81 - $287.01 $213,234 - $261,753	-912 Reduced 0.58%	155,671 $42.8 Million
Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $4.6 Million - $7.93 Million	32,120 Added 25.81%	156,583 $38 Million
Q1 2024 May 13, 2024	BUY	$146.51 - $198.2 $4.98 Million - $6.74 Million	33,990 Added 37.57%	124,463 $18.6 Million
Q4 2023 Feb 09, 2024	BUY	$151.41 - $196.57 $3.11 Million - $4.04 Million	20,571 Added 29.43%	90,473 $17.3 Million
Q3 2023 Nov 09, 2023	SELL	$170.77 - $211.65 $621,773 - $770,617	-3,641 Reduced 4.95%	69,902 $12.4 Million
Q2 2023 Aug 11, 2023	BUY	$185.01 - $212.05 $6.19 Million - $7.09 Million	33,439 Added 83.38%	73,543 $14 Million
Q1 2023 May 12, 2023	SELL	$182.66 - $235.53 $1.32 Million - $1.71 Million	-7,247 Reduced 15.3%	40,104 $8.03 Million
Q4 2022 Feb 08, 2023	BUY	$185.53 - $241.31 $307,052 - $399,368	1,655 Added 3.62%	47,351 $11.3 Million
Q3 2022 Nov 10, 2022	BUY	$138.54 - $232.0 $2.86 Million - $4.79 Million	20,629 Added 82.3%	45,696 $9.15 Million
Q2 2022 Aug 10, 2022	SELL	$120.42 - $169.29 $350,301 - $492,464	-2,909 Reduced 10.4%	25,067 $3.66 Million
Q1 2022 May 16, 2022	SELL	$127.18 - $173.91 $7.82 Million - $10.7 Million	-61,497 Reduced 68.73%	27,976 $4.57 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $10.7 Million - $14.1 Million	67,281 Added 303.18%	89,473 $15.2 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $601,424 - $735,987	3,543 Added 19.0%	22,192 $4.19 Million
Q2 2021 Aug 13, 2021	SELL	$128.63 - $176.89 $330,964 - $455,137	-2,573 Reduced 12.12%	18,649 $3.16 Million
Q1 2021 May 12, 2021	BUY	$126.83 - $175.69 $10,400 - $14,406	82 Added 0.39%	21,222 $3 Million
Q4 2020 Feb 11, 2021	SELL	$122.97 - $147.0 $92,965 - $111,132	-756 Reduced 3.45%	21,140 $2.75 Million
Q3 2020 Nov 12, 2020	SELL	$121.19 - $165.49 $302,005 - $412,401	-2,492 Reduced 10.22%	21,896 $3.19 Million
Q2 2020 Jul 31, 2020	SELL	$104.21 - $156.44 $1.83 Million - $2.74 Million	-17,538 Reduced 41.83%	24,388 $3.61 Million
Q1 2020 May 01, 2020	BUY	$93.12 - $133.99 $851,675 - $1.23 Million	9,146 Added 27.9%	41,926 $4.56 Million
Q4 2019 Feb 14, 2020	SELL	$74.51 - $124.23 $2.85 Million - $4.76 Million	-38,285 Reduced 53.87%	32,780 $3.78 Million
Q3 2019 Nov 14, 2019	BUY	$70.9 - $87.82 $3.03 Million - $3.75 Million	42,701 Added 150.55%	71,065 $5.71 Million
Q2 2019 Aug 14, 2019	SELL	$65.86 - $92.79 $1.33 Million - $1.88 Million	-20,270 Reduced 41.68%	28,364 $2.06 Million
Q1 2019 May 14, 2019	SELL	$72.76 - $93.45 $4.07 Million - $5.23 Million	-55,999 Reduced 53.52%	48,634 $4.54 Million
Q4 2018 Feb 14, 2019	BUY	$62.67 - $88.33 $737,688 - $1.04 Million	11,771 Added 12.68%	104,633 $7.63 Million
Q3 2018 Nov 14, 2018	BUY	$87.52 - $122.67 $3.4 Million - $4.76 Million	38,830 Added 71.86%	92,862 $8.13 Million
Q2 2018 Aug 14, 2018	SELL	$88.31 - $107.8 $3.88 Million - $4.74 Million	-43,989 Reduced 44.88%	54,032 $5.32 Million
Q1 2018 May 15, 2018	BUY	$115.92 - $148.54 $2.1 Million - $2.69 Million	18,107 Added 22.66%	98,021 $11.7 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $4.18 Million - $5.12 Million	36,548 Added 84.28%	79,914 $10.2 Million
Q3 2017 Nov 14, 2017	SELL	$72.53 - $118.27 $1.65 Million - $2.68 Million	-22,701 Reduced 34.36%	43,366 $5.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	4,082 Added 6.59%	66,067 $5.27 Million
Q1 2017 Nov 14, 2017	BUY	N/A	61,985	61,985 $3.18 Million

Others Institutions Holding ALNY

# of Institutions

642

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.1B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account